Development of a New Similarity Index to Compare Time-series Profile Data for Animal and Human Experiments |
Lee, Ye Gyoung
(Department of Industiral & Management Systems Engineering, Dong-A University)
Lee, Hyun Jeong (Department of Industiral & Management Systems Engineering, Dong-A University) Jang, Hyeon Ae (Department of Frontier Convergence Engineering, JEONJU University) Shin, Sangmun (Department of Industiral & Management Systems Engineering, Dong-A University) |
1 | Kang WH., Hwang JA., Chae JW., Kwon KI., and Yun HY. 2019. The Role Change of Drug Metabolism and Pharmacokinetics Research in the Drug Development. Yakhak Hoeji 63(3):121-130. DOI |
2 | KFDA. 2011. Bioequivalence Test Professional Education Manual. |
3 | Kola I., Landis J. 2004. Can the Pharmaceutical Industry Reduce Rates?. Nature Reviews Drug Discovery 3(8):711-6. DOI |
4 | Lee DK. 2016. Analysis of Process Capability Index for Multiple Measurements. Journal of Society of Korea Industrial and Systems Engineering 39(1):91-7. DOI |
5 | Lee YJ., Kim YG., Lee MG., Chung SJ., Lee MH., and Shim CK. 2000. Analysis of Bioequivalence Study using a Log-transformation Model. Yakhak Hoeji 44(4):308-14. |
6 | Mahalanobis PC. 1936. On the Generalized Distance in Statistics. National Institute of Sciences of India 2(1):49-55. |
7 | Prueksaritanont T., Tang C. 2012. ADME of Biologics-What Have We Learned from Small Molecules?. The AAPS Journal 14(3):410-9. DOI |
8 | Shin DS. 2016. Study on Estimated Methods for Parmacokinetics Profiles of Drugs Discovery. MS diss., Dong-A University. |
9 | Lee HJ. 2020. Study on a Similarity Index of the Pharmacokinetic Profiles for Clinical and Nonclinical Trials. MS diss., Dong-A University. |
10 | Brereton RG. 2015. The Mahalanobis Distance and its Relationship to Principal Component Scores. Journal of Chemometrics 29(3):143-5. DOI |
11 | Chan LK., Cheng SW., and Spiring F. 1988. A New Measure of Process Capability: Cpm. Journal of Quality Technology 20(3):162-175. DOI |
12 | De Maesschlck R., Jouan-Rimbaud D., and Massart DL. 2000. The Mahalanobis Distance. Chemometrics and Intelligent Laboratory Systems 50(1):1-18. DOI |
13 | DiMasi JA., Feldman L., Seckler A., and Wilson A. 2010. Trends in Risks Associated with New Drug Development: Success Rates for Investigational Drugs. Clionical Pharmacology & Therapeutics 87(3):272-7. DOI |
14 | Gnanadesikan R., Kettenring JR. 1972. Robust Estimates, Residuals, and Outlier Detection with Multiresponse Data. Biometrics:81-124. |
15 | Jung JH. 2018. A Study on Similarity Evaluation Methodologies for Identifying the Correlation between Clinical and Nonclinical Trials on a Pharmaceutical Formulation Development. MS diss., Dong-A University. |